ALRT .035 non compliant. Possibly gain compliance, company says to the SEC by Jan 28th
OBMP .056 Phase 2 trials starting soon, prosovax prostate cancer vaccine. Trial to be at Beth Israel Harvard Medical. Also an ovarian cancer trial.
IPIX .65 Data in a few weeks - a month. A lot on the grinder by year end.
"Perfection is not attainable, but if we chase perfection we can catch excellence." Vince Lombardi Do your research! Play the TA. All posts are my opinion.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.